|
2022 Journal Article Cytokine/Chemokine assessment as a complementary diagnostic tool for inflammatory skin diseasesLiu, Timothy J., Lin, Lynlee L., McMeniman, Erin, Wu, Jason, Kao, Yung-Ching, Kumari, Snehlata, Boyle, Glen M., Wells, James W., Soyer, H. Peter and Gonzalez-Cruz, Jazmina L. (2022). Cytokine/Chemokine assessment as a complementary diagnostic tool for inflammatory skin diseases. Frontiers in Immunology, 13 1028435, 1-8. doi: 10.3389/fimmu.2022.1028435 |
|
2022 Journal Article Consumer perceptions on privacy and confidentiality in dermatology for 3D total‐body imagingHorsham, Caitlin, Janda, Monika, Kerr, Melissa, Soyer, H. Peter and Caffery, Liam J. (2022). Consumer perceptions on privacy and confidentiality in dermatology for 3D total‐body imaging. Australasian Journal of Dermatology, 64 (1), 118-3. doi: 10.1111/ajd.13952 |
|
2022 Journal Article Digital skin imaging applications, part II: a comprehensive survey of post-acquisition image utilization features and technology standardsSun, Mary D., Kentley, Jonathan, Wilson, Britney W., Soyer, H. Peter, Curiel-Lewandrowski, Clara N., Rotemberg, Veronica M. and Halpern, Allan C. (2022). Digital skin imaging applications, part II: a comprehensive survey of post-acquisition image utilization features and technology standards. Skin Research and Technology, 28 (6), 771-779. doi: 10.1111/srt.13195 |
|
2022 Journal Article The daily use of dermoscopy in the Netherlands The daily use of dermoscopy in the NetherlandsZoutendijk, Judith, Siem, Denny, Argenziano, Giuseppe, Forsea, Ana-Maria, Geller, Alan, Del Marmol, Veronique, Zalaudek, Iris, Soyer, Peter and Kukutsch, Nicole (2022). The daily use of dermoscopy in the Netherlands The daily use of dermoscopy in the Netherlands. European journal of dermatology : EJD, 32 (6), 736-742. doi: 10.1684/ejd.2022.4377 |
|
2022 Journal Article Attitudes of Australian dermatologists on the use of genetic testing: A cross-sectional survey with a focus on melanomaPrimiero, Clare A., Baker, Amy M., Wallingford, Courtney K., Maas, Ellie J., Yanes, Tatiane, Fowles, Lindsay, Janda, Monika, Young, Mary-Anne, Nisselle, Amy, Terrill, Bronwyn, Lodge, Jason M., Tiller, Jane M., Lacaze, Paul, Andersen, Hayley, McErlean, Gemma, Turbitt, Erin, Soyer, H. Peter and McInerney-Leo, Aideen M. (2022). Attitudes of Australian dermatologists on the use of genetic testing: A cross-sectional survey with a focus on melanoma. Frontiers in Genetics, 13 919134, 1-12. doi: 10.3389/fgene.2022.919134 |
|
2022 Journal Article Measurable outcomes of consumer engagement in health research: A scoping reviewDeBortoli, Emily, Soyer, H. Peter, Milne, David, Dissanayaka, Nadeeka, Gartner, Coral, Holt, Jeanette, Rae, Kym, Robison, Laura, Wallingford, Courtney K. and McInerney-Leo, Aideen M. (2022). Measurable outcomes of consumer engagement in health research: A scoping review. Frontiers in Public Health, 10 994547, 1-10. doi: 10.3389/fpubh.2022.994547 |
|
2022 Journal Article Can people take high‐quality images using mobile dermatoscopes at home on easy‐to‐see and difficult‐to‐see body areas?Rodriguez‐Acevedo, Astrid J., O'Hara, Montana, Koh, Uyen, Betz‐Stablein, Brigid, Horsham, Caitlin, Soyer, H. Peter and Janda, Monika (2022). Can people take high‐quality images using mobile dermatoscopes at home on easy‐to‐see and difficult‐to‐see body areas?. Journal of the European Academy of Dermatology and Venereology, 37 (2), e155-e157. doi: 10.1111/jdv.18633 |
|
2022 Journal Article Perspectives and experiences of patient-led melanoma surveillance using digital technologies from clinicians involved in the MEL-SELF pilot randomised controlled trial: Qualitative interview studyDrabarek, Dorothy, Habgood, Emily, Ackerman, Deonna, Hersch, Jolyn, Janda, Monika, Morton, Rachael L, Guitera, Pascale, Soyer, Hans Peter, Collgros, Helena, Cust, Anne E, Saw, Robyn PM, Emery, Jon, Mar, Victoria, Dieng, Mbathio, Azzi, Anthony, Lilleyman, Alister and Bell, Katy JL (2022). Perspectives and experiences of patient-led melanoma surveillance using digital technologies from clinicians involved in the MEL-SELF pilot randomised controlled trial: Qualitative interview study. JMIR Dermatology, 5 (4) e40623, e40623. doi: 10.2196/40623 |
|
2022 Journal Article Incidence of in situ vs invasive melanoma: testing the “obligate precursor” hypothesisOlsen, Catherine M., Pandeya, Nirmala, Rosenberg, Philip S. and Whiteman, David C. (2022). Incidence of in situ vs invasive melanoma: testing the “obligate precursor” hypothesis. JNCI: Journal of the National Cancer Institute, 114 (10), 1364-1370. doi: 10.1093/jnci/djac138 |
|
2022 Journal Article Indications for digital monitoring of patients with multiple nevi: recommendations from the international dermoscopy societyRusso, Teresa, Piccolo, Vincenzo, Moscarella, Elvira, Tschandl, Philipp, Kittler, Harald, Paoli, John, Lallas, Aimilios, Braun, Ralph P., Thomas, Luc, Soyer, H. Peter, Malvehy, Josep, Puig, Susana, Marghoob, Ashfaq, Scope, Alon, Blum, Andreas, Halpern, Allan C., Cabo, Horacio, Menzies, Scott, Stolz, Wilhelm, Tanaka, Masaru, Rabinovitz, Harold, Hofmann-Wellenhof, Rainer, Bakos, Renato Marchiori, Zalaudek, Iris, Pellacani, Giovanni, Veiga, Ana Varela, Maceiras, Laura Rosende, de las Heras-Sotos, Cristina and Argenziano, Giuseppe (2022). Indications for digital monitoring of patients with multiple nevi: recommendations from the international dermoscopy society. Dermatology Practical and Conceptual, 12 (4) e2022182, 1-8. doi: 10.5826/dpc.1204a182 |
|
2022 Journal Article Body site distribution of acquired melanocytic naevi and associated characteristics in the general population of caucasian adults: a scoping reviewJayasinghe, Dilki, Nufer, Kaitlin L., Betz-Stablein, Brigid, Soyer, H. Peter and Janda, Monika (2022). Body site distribution of acquired melanocytic naevi and associated characteristics in the general population of caucasian adults: a scoping review. Dermatology and Therapy, 12 (11), 2453-2488. doi: 10.1007/s13555-022-00806-x |
|
2022 Journal Article Assessing the value of precision medicine health technologies to detect and manage melanomaMahumud, Rashidul A., Janda, Monika, Soyer, H. Peter, Fernández-Peñas, Pablo, Mar, Victoria J. and Morton, Rachael L. (2022). Assessing the value of precision medicine health technologies to detect and manage melanoma. Medical Journal of Australia, 217 (6), 275-278. doi: 10.5694/mja2.51696 |
|
2022 Journal Article Developing an Australian Melanoma Clinical Outcomes Registry (MelCOR): a protocol paperJobson, Dale, Roffey, Benjamin, Best, Renee, Button-Sloan, Alison, Cossio, Danica, Evans, Sue, Shang, Catherine, Moore, Julie, Arnold, Christopher, Mann, Graham, Shackleton, Mark, Soyer, H. Peter, Morton, Rachel L., Zalcberg, John and Mar, Victoria (2022). Developing an Australian Melanoma Clinical Outcomes Registry (MelCOR): a protocol paper. BMJ Open, 12 (9) e062139, 1-6. doi: 10.1136/bmjopen-2022-062139 |
|
2022 Journal Article Development of melanoma clinical quality indicators for the Australian melanoma clinical outcomes registry ( MelCOR ): a modified delphi studyJobson, Dale, Roffey, Benjamin, Arnold, Christopher, Azzi, Anthony, Button‐Sloan, Alison, Dawson, Tamara, Fernandez‐Penas, Pablo, Fishburn, Paul, Gyorki, David E., Hiscutt, Emma L., Jakrot, Valerie, Lilleyman, Alister, Lochhead, Alistair, Long, Georgina V., Mailer, Sonia, Mann, Graham, McCormack, Christopher J., Muir, Jim, Pratt, George F., Scolyer, Richard A., Shackelton, Mark, Shumack, Stephen, Soyer, H. Peter, Tan, Chin‐Guan, Webb, Angela, Zalcberg, John, Morton, Rachael and Mar, Victoria (2022). Development of melanoma clinical quality indicators for the Australian melanoma clinical outcomes registry ( MelCOR ): a modified delphi study. Australasian Journal of Dermatology, 63 (3), 344-351. doi: 10.1111/ajd.13848 |
|
2022 Journal Article A robust experimental and computational analysis framework at multiple resolutions, modalities and coveragesTran, M., Yoon, S., Teoh, M., Andersen, S., Lam, PY., Purdue, B. W., Raghubar, A., Hanson, S.J., Devitt, K., Jones, K., Walters, S., Monkman, J., Kulasinghe, A., Tuong, Z.K., Soyer, H.P., Frazer, I. H. and Nguyen, Q. (2022). A robust experimental and computational analysis framework at multiple resolutions, modalities and coverages. Frontiers in Immunology, 13 911873, 911873. doi: 10.3389/fimmu.2022.911873 |
|
2022 Journal Article Amelanotic/hypopigmented melanoma in a sibship with oculocutaneous albinismMaas, Ellie J, Wallingford, Courtney K, McGuire, Jessica J, Rutjes, Chantal, Smit, Darren J, Betz-Stablein, Brigid, Sturm, Richard A, Soyer, H Peter and McInerney-Leo, Aideen M (2022). Amelanotic/hypopigmented melanoma in a sibship with oculocutaneous albinism. The Journal of Dermatology, 49 (11), 1183-1187. doi: 10.1111/1346-8138.16528 |
|
2022 Journal Article Genome-scale DNA methylation analysis identifies repeat element alterations that modulate the genomic stability of melanocytic neviMuse, Meghan E., Bergman, Drew T., Salas, Lucas A., Tom, Lisa N., Tan, Jean-Marie, Laino, Antonia, Lambie, Duncan, Sturm, Richard A., Schaider, Helmut, Soyer, H. Peter, Christensen, Brock C. and Stark, Mitchell S. (2022). Genome-scale DNA methylation analysis identifies repeat element alterations that modulate the genomic stability of melanocytic nevi. The Journal of Investigative Dermatology, 142 (7), 1893-1902.e7. doi: 10.1016/j.jid.2021.11.025 |
|
2022 Journal Article Digital skin imaging applications, part I: assessment of image acquisition technique featuresSun, Mary D., Kentley, Jonathan, Wilson, Britney W., Soyer, H. Peter, Curiel-Lewandrowski, Clara N., Rotemberg, Veronica and Halpern, Allan C. (2022). Digital skin imaging applications, part I: assessment of image acquisition technique features. Skin Research and Technology, 28 (4), 623-632. doi: 10.1111/srt.13163 |
|
2022 Journal Article In-depth characterisation of real-world advanced melanoma patients receiving immunotherapies and/or targeted therapies: a case seriesSanjida, Saira, Betz-Stablein, Brigid, Atkinson, Victoria, Janda, Monika, Barsoum, Ramez, Edwards, Harrison Aljian, Chiu, Frank, Tran, My Co, Soyer, H. Peter and Schaider, Helmut (2022). In-depth characterisation of real-world advanced melanoma patients receiving immunotherapies and/or targeted therapies: a case series. Cancers, 14 (11) 2801, 2801. doi: 10.3390/cancers14112801 |
|
2022 Journal Article Genome-wide association study suggests the variant rs7551288*A within the DHCR24 gene is associated with poor overall survival in melanoma patientsPflugfelder, Annette, Yong, Xuan Ling Hilary, Jagirdar, Kasturee, Eigentler, Thomas K., Soyer, H. Peter, Sturm, Richard A., Flatz, Lukas and Duffy, David L. (2022). Genome-wide association study suggests the variant rs7551288*A within the DHCR24 gene is associated with poor overall survival in melanoma patients. Cancers, 14 (10) 2410, 2410. doi: 10.3390/cancers14102410 |
